Obstetrics

 
 APOSTEL VIII
 
 Dutch TRUFFLE
 
 2Close
 
 APRIL
 Highlow
 
 PC
 Quadruple P
 
 SIMPLE III
 
 Stop or Go?
 
 STRIDER
 
 SUGAR-DIP
 
 KEUZEHULP IMPLEMENTATIE
 
 INDEX
 MOTHER
 NethOSS
 Ppromexil-III
 ALLO
 AMPHIA
 APOSTEL-I
 APOSTEL-II
 APOSTEL-III
 APOSTEL-IV
 
 Apostel VI
 ASB
 CHIPS
 DIGITAT
 ECV Implementation
 EuFis
 Fluxim
 GlucoMOMS
 HTA Longterm conseq.
 HTA Preference study
 HYPITAT
 HYPITAT-II
 HyRAS (Hypitat followup)
 Implementatie Tour
 IUPC
 PIMPP
 PPROMCerclage
 PPROMEXIL
 PreCare
 PROBAAT
 PROBAAT-II
 PROBAAT-S
 ProTWIN
 SimpleII
 STAN
 TeMpOH-1
 TeMpOH-3
 TOSTI
 TOTEM
 Triple P
 TRUFFLE
 WOMB study

 ABCD-study
 BIG CHANGE
 CAMPUR
 Cancer in pregnancy
 Doula study
 ECV tocolysis
 ECV Uterine relaxation
 EuroHeartSurvey
 FRUIT
 HP4ALL-PC
 HP4ALL-RS
 IMPACT
 INCAS
 IRIS
 Keizerlijk litteken
 MAKE
 OOPUS
 PRELHUDE
 PROMISES
 RAVEL
 > SIMPLE
 STAN followup
 VET study
 VIS-project
 Wat bevalt beter
 ZAHARA II
 ZAHARA 3
 ZOBASII
 

 

SIMPLE study
 

Sectio implementie studie

 

Current Dutch practice on caesarean sections: Identification of barriers and facilitators for optimal care

 

Go to the SIMPLE website


Objective
Caesarean (CS) delivery rates continue to increase worldwide. In the last 20 years the CS rate in the Netherlands increased from 5 to 15%. CS have no clear benefit for overall neonatal outcome and are associated with higher maternal complications and high costs. Dutch guidelines offer different clear recommendations on factors that have a direct effect on the decision to perform a CS. This study aims to provide insight into current adherence of Dutch gynaecologists to these guideline recommendations. Moreover, facilitators and barriers for guideline non-adherence are studied and a tailored implementation strategy will be developed and tested in a feasibility study.

 

Study design
The current Dutch care will be studied in 20 hospitals (N=80 gynaecologists). After the development of quality indicators 1000 files on the performed CS are analyzed regarding the adherence to the guideline recommendations. To get insight into Dutch practices compared to international data, basic obstetrical data will be extracted from the delivery database. A barrier analysis will be carried out based on the results of the current care study. Two groups of hospitals will be identified in the upper and lower extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals with the highest adherence scores. Factors that determine the decision to perform a CS or not (barriers and facilitators) will be analyzed in both groups using semi-structured interviews among 15-20 health care professionals and 15-20 patients. A questionnaire will be used to study the 'prevalence' of these factors among all obstetric gynaecologists in the Netherlands and among 200 experienced patients. Based on the outcomes of the current care study and the barrier analysis, an implementation strategy will be developed and tested.

Study population
Current care study:

All women (1000) who underwent a CS in one of the 20 participating hospitals during the study period of 3-4 months.

 

Barrier analysis

Qualitative: 15-20 health care professionals and 15-20 experienced patients from the hospitals in the upper and lower extremes of the 'adherence distribution'.

Quantitative: all obstetric gynaecologists in the Netherlands and among 200 experienced patients.

 

Intervention
The intervention will be developed as part of the study.

 

Outcome measures
Current care study:

The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care and the number of preventable CS.

Furthermore, Dutch practice as compared to international data.

 

Barrier analysis

Factors that determine the decision to perform a CS or not (barriers and facilitators).

 

Power/data analysis
In the current care study, in 20 hospitals a sample size of 80 professionals and 1000 patients need to be included assuming a deviation from the recommendations of 25%, a precision of 5% and an ICC of 0,2.


Time schedule
Assessment of quality indicators: 5 months

Data gathering and interviews: 12 months

Development implementation strategy: 6 months

Feasibility study: 12 months

Analysis feasibility study: 3 months


Projectleaders
Dr. H.C.J. Scheepers, Maastricht UMC

Dr. R.P.M.G. Hermens, IQ Healthcare Nijmegen

 

Projectmembers

Prof. Dr. J. G. Nijhuis, Maastricht UMC

Drs. S. Melman, Maastricht UMC

Dr. A. Kwee, UMC Utrecht


Health Technology Assessment
Dr. C. Dirksen, HTA Maastricht UMC


Subsidy
ZonMW - www.ZonMW.nl

 

Contact

Drs. Sonja Melman, arts-onderzoeker,

Maastricht Universitair Medisch Centrum, P. Debyelaan 28, 6229 HX Maastricht

Tel: 043 3874768

E-Mail: simple@studies-obsgyn.nl